Lataa...
Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury
Purpose: HDAC3 regulates nuclear atrophy as an early response to axonal injury in retinal ganglion cells (RGCs) following optic nerve crush (ONC). Since conditional knockout of Hdac3 prevents nuclear atrophy post ONC, HDAC3 selective inhibition with RGFP966 through localized and systemic dosing of R...
Tallennettuna:
| Julkaisussa: | J Ocul Pharmacol Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mary Ann Liebert, Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5963665/ https://ncbi.nlm.nih.gov/pubmed/29211617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2017.0059 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|